Eqwires | Stock Market Advisory

Rail Vikas Nigam Ltd (RVNL)share price gained up to 4% in the intraday trades on Wednesday on ₹404 crore order update.

Rail Vikas Nigam Ltd (RVNL)share price opened at ₹410.05 on the BSE on Wednesday, more than 2% higher than the previous closing price of ₹400.20. The RVVNL share price thereafter gained further to highs of ₹416.30 which meant gains of more than 4%

The Rail Vikas Nigam Ltd share price has corrected significantly from 52 week highs of ₹647 in July. However order book remains strong and is growing

Rail Vikas Nigam Ltd (RVNL) order details

Rail Vikas Nigam Ltd in its intimation to exchanges on 4 February 2025 informed about receiving Letter of Acceptance received from East Coast Railway.

Rail Vikas Nigam Limited in its intimation said that it has received Letter of Acceptance from East Coast Railway for “Koraput-Singapur Road Doubling Project: Execution of 27 Nos of Major Bridges i.e. (22 Nos of Major Bridges & 5 Nos of ROBs) and earth work in formation of approaches, protection works and other connected miscellaneous works between Tikiri and Bhalumaska stations in connection with Koraput-Singapur Road Doubling Project of Waltair Division, East Coast Railway.

The time period for the completion by Rail Vikas Nigam Ltd is 30 Months

The broad consideration or the project cost is ₹404,40,32,985.00/- (Rupees Four Hundred Four Crore Forty Lakh Thirty Two Thousand Nine Hundred Eighty Five Only) (Including GST)

While the order boosted the investors sentiments, leading to 4% gains for the stock, nevertheless the stock gave up part of the gains. The investors will be watchful of RVNL Q3 performance to be declared soon.

RVNL also in another intimation to the exchanges on 4 January said that the meeting of the Board of Directors of Rail Vikas Nigam Ltd is scheduled on 12/02/2025 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and nine months ended 31st December, 2024

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram | Facebook | Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Shares of Gland Pharma slipped 5 per cent to Rs 1,437.70 on the BSE in Tuesday’s intra-day trade after the company’s revenues de-grew 10 per cent year-on-year (YoY) to Rs 1,384 crore in the December quarter (Q3FY25). The company’s topline was impacted by the low base business arising due to a dip in volumes in the US as well as some shipment delays to Saudi Arabia. 

In comparison, the BSE Sensex was up 0.3 per cent at 77,417, at 10:40 AM. The stock price of Gland Pharma had hit a 52-week low of Rs 1,413.75 on January 28, 2025. It has corrected 35 per cent from its 52-week high level of Rs 2,220.95 touched on August 6, 2024.

The company’ reported earnings before interest, tax, depreciation and amortisation (Ebitda), on the other hand, grew 1 per cent YoY to Rs 360 crore, and margins stood at 26 per cent (300 bps growth) driven by a strong 535 bps improvement in gross profit margin. Profit after tax grew 7 per cent YoY to Rs 204.7 crore. 

In the base business, the US de-grew 12 per cent YoY to Rs 713.5 crore due to a postponement of supplies of blood thinner, Enoxaparin to the next quarter. Rest of world (RoW) reported 6 per cent YoY growth to Rs 167 crore, while the domestic business de-grew 26 per cent YoY to Rs 56 crore. The Cenexi business remained impacted due to machinery breakdown in a Belgium plant and to address observations emanating from an unannounced inspection by the French regulator.

On a negative note, the company’s management now expects the Cenexi turnaround to happen in Q3FY26F (vs. Q4FY25F earlier), given the Lyophilizer breakdown at the Belgium plant and the observations received for the Fontenay, Belgium, plant from the French health authorities at the recent inspection.

ICICI Securities said Gland’s base business revenues were negatively impacted by the postponement of Enoxaparin revenues to the next quarter but this had positive implications on the margins as Enoxaparin fetches lower margins. The Cenexi business was also impacted by unforeseen events, however the postponement of positive margins (Ebitda) to Q3FY26 is a matter of slight concern. 

That said, the brokerage firm expects normalcy to return in a quarter or two. The future holds good for Gland with the expected approvals for complex products , GLP 1 contract signing and an agreement with a Chinese biotech player for biosimilars besides incremental Cenexi revenues from the new high-speed line from Fontenay plant. The new CEO has been assigned to take charge of RoW and India businesses, ICICI Securities said in a note. 

Analysts at InCred Equities said they are disappointed with the repeated delay in Cenexi’s turnaround and will reassess the situation constructively once the facility is back on track. It has been nearly seven quarters since Cenexi’s acquisition, and it will take another three-to-four quarters for the business to normalise, they said. 

While Gland’s core business continues to outperform, Cenexi’s ongoing challenges will remain a drag in the near-term. As a result, the brokerage firm has reduced its FY25F/26F EPS estimates by 14 per cent/24 per cent, respectively, and lowered the target price to Rs 1,313, from Rs 1,768 earlier. A faster-than-expected ramp-up at Cenexi remains a key upside risk, the brokerage firm said in the company’s results update.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram | Facebook | Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Shares of Coromandel International, GTV Engineering, Indian Metals & Ferro Alloys, Dr Lal PathLabs, Manba Finance, MAS Financial Services, Shree Cement, SMC Global Securities, and Sona BLW Precision Forgings are set to remain in focus during today’s trading session on account of their interim dividend announcements. Notably, shares of all these companies are slated to turn ex-dividend tomorrow, February 5, 2025, according to BSE data. 

Among them, Shree Cement has announced the highest dividend of Rs 50 per share for its shareholders. The company has set the record date as February 5, 2025, to ascertain shareholder’s eligibility for this dividend.

Further, Coromandel International, Indian Metals & Ferro Alloys, and GTV Engineering have announced interim dividends of Rs 6, Rs 5, and Rs 0.50 per share, respectively. All three companies have also set the record date as February 5, 2025, for the payout. 

Dr Lal PathLabs, Manba Finance, and MAS Financial Services have declared interim dividends of Rs 6, Rs 0.25, and Rs 1 per share, respectively. These companies have also set the record date as February 5, 2025. 

Meanwhile, SMC Global Securities, and Sona BLW Precision Forgings have announced interim dividends of Rs 1.20 and Rs 1.60 per share, respectively, with their record date set for February 5, 2025.

Besides these, Aarti Drugs, Aurionpro Solutions, Emami, KPIT Technologies, LT Foods, Orient Electric, and SRF will remain in focus today as they turn ex-dividend. Meanwhile, Redtape is set to gain attention as it turns ex-bonus today. 

Notably, the ex-date and record date are key markers for determining shareholder eligibility for dividend rewards. The ex-date marks the day a stock begins trading without dividend entitlement. To qualify for dividend benefits, investors must hold the stock before this date. The list of eligible shareholders is finalized based on records maintained at the close of the record date.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram | Facebook | Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

The NSE Nifty 50 index has surged over 1 per cent in intra-day deals on Tuesday, and is now seen quoting above its super trend line on the daily scale for the first time since December 19, 2024. A close above 23,604, shall qualify as a positive breakout for the Nifty on the daily scale.

At the high point of the day so far, at 23,659, the Nifty gained 3.8 per cent from its recent low of 22,787. That apart, the Nifty 50 is seen quoting above its 20-DMA (Daily Moving Average) for the fourth straight trading session.

Technically, the Nifty is now seen clearing its first key hurdle as the index attempts a pullback from its record high of 26,277. The Nifty 50 had shed 13.3 per cent or almost 3,500 points from the peak in the last four months.

Amid the attempted recovery, the Nifty can potentially attempt a rebound towards 24,250 levels. The next key hurdle for the Nifty is placed around 23,780 levels, above which resistance can be expected around 24,020 and 24,150 levels.

The near-term bias for the Nifty is likely to remain upbeat as long as the index holds above 23,500 levels; below which the key support for the index stands at the 20-DMA (Daily Moving Average) at 23,250.

The BSE Sensex, meanwhile, is seen quoting around 78,150 levels. The BSE benchmark has gained nearly 2,900 points from its recent low at 75,267.

The quarterly Fibonacci chart suggests that sustained trade above 78,150, shall pave the way for a likely rally towards 80,000-mark, above which a test of 81,150 seems likely. Interim resistance for the Sensex can be expected around 78,635 and 79,335 levels.  In case of a dip, the BSE Sensex may seek support around 77,500 levels.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram | Facebook | Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

One 97 Communications, parent company of Paytm, shares gained 5.2 per cent on Monday, logging an intraday high at Rs 782.8 per share on BSE. The northward rally in the stock came after the company arm Paytm Cloud Technologies’ board approved an investment of $1 million (Rs 8.7 crore) in Seven Technology LLC. 

Around 12:06 PM, Paytm share price was up 4.41 per cent at Rs 776.4 per share on BSE. In comparison, the BSE Sensex was down 0.67 per cent at 76,988.21. The market capitalisation of the company stood at Rs 49,497.9 crore. The 52-week high of the stock was at Rs 1,063 per share and the 52-week low was at Rs 310 per share. 

Paytm Cloud Technologies will acquire a 25 per cent stake in  Seven Technology LLC with the $1 million investment.  

“We have been informed by Paytm Cloud Technologies Limited, our wholly-owned subsidiary, that the Board of Directors of PCTL at its meeting held on February 3, 2025 and concluded at 08:15 a.m. (IST) has approved an investment of $1 million (equivalent to Rs 8.70 crore) in Seven Technology LLC incorporated in Delaware for the acquisition of a 25 per cent stake and execution of transaction documents in this regard,” the filing read. 

Seven Technology LLC is the parent company of Dinie Correspondente Bancário e Meios de Pagamento Ltda. (“Dinie”), Brazil-based API-first embedded finance start-up. Dinie enables digital/ e-commerce platforms to provide digital financial services solutions to micro, small, and medium-sized enterprises (MSMEs) in Brazil. Post-consummation of the transaction, Seven Technology LLC and Dinie will become associate entities of the company. 

The company believes technology-led merchant payments and financial services distribution business model in India, has the potential for expansion in similar international markets. 

This latest investment in an overseas market comes weeks after Paytm sold its stake in a Japanese company for $250 million.

One97 Communications Singapore approved the sale of Stock Acquisition Rights (SARs) held in Japan-based PayPay Corporation last year. Paytm’s Singapore unit acquired these SARs in September 2020. 

In the past one year, Paytm shares have 69 per cent against Sensex’s rise of 8 per cent. 

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram | Facebook | Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com